Concepedia

Catherine Cannon

CC

Statistics

Publications

7

Citations

5.2K

H-Index

7

Active since

1990

Affiliations

Athena Group (United States)(Current)

Catherine Cannon is an author at Athena Group (United States) specializing in life sciences, monoclonal antibodies, and neuroscience.

Publications per year

1990–2003

7

Publications

7

Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

Frédérique Bard, Catherine Cannon, Robin Barbour et al. · Nature Medicine · 2000 · 2K citations

, , +17

Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin

Ted Yednock, Catherine Cannon, Lawrence C. Fritz et al. · Nature · 1992 · 1.7K citations

, , +12

A cell culture model of the blood-brain barrier.

Lee L. Rubin, Deborah E. Hall, Stephen Porter et al. · The Journal of Cell Biology · 1991 · 774 citations · Full text

, , +17

Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathology

Frédérique Bard, Robin Barbour, Catherine Cannon et al. · Proceedings of the National Academy of Sciences · 2003 · 407 citations

, , +17

α4β1Integrin-dependent Cell Adhesion Is Regulated by a Low Affinity Receptor Pool That Is Conformationally Responsive to Ligand

Ted Yednock, Catherine Cannon, Christopher Vandevert et al. · Journal of Biological Chemistry · 1995 · 141 citations · Full text

, , +17

1–5 of 7